Deciphera Pharmaceuticals, Inc. (DCPH) Social Stream



Deciphera Pharmaceuticals, Inc. (DCPH): $8.00

-0.63 (-7.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DCPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

Featured Post From StockTwits About DCPH

$DCPH New here. So considering the serious side effects of QINLOCK such as skin cancer, hypertension and heart problems to mention a few, is it safe to say the European Medicines Agency known for their strictness when it comes to approving drugs with serious side effects, might refuse to approve QINLOCK?
Tracy2021, published August 11, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.591 seconds.